← SynDRA
TIZANIDINE
SynDRA canonical compound SYN0003529 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | ADRA2A | ADRA2B | ADRA2C | CYP1A2 | NISCH |
| Mechanism of action | adrenergic receptor agonist |
| Indication | spasms |
| Disease area | neurology/psychiatry |
All known targets
- ADRA2A
- ADRA2B
- ADRA2C
- NISCH
- ADRA1A
- CYP1A2
Mechanisms of action (all sources)
- ADRA2A AGONIST
- Adrenergic receptor alpha-2 agonist
- ADRA2C AGONIST
- ADRA2B AGONIST
- adrenergic receptor agonist
Drug classes
- Adrenergic alpha2-Agonists
- Central alpha-2 Adrenergic Agonist
- Anticonvulsants
- Adrenergic Agents
- Adrenergic Agonists
- Adrenergic alpha-2 Receptor Agonists
- Adrenergic alpha-Agonists
- Analgesics
- Central Nervous System Agents
- Muscle Relaxants, Central
- Neuromuscular Agents
- Neurotransmitter Agents
ATC classes
- M03B · MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS
Cross-references
Synonyms
- DS 103-282
- tizanidine hydrochloride
- tizanidine HCl
- AN021
- DS103-282
- Tizanidina
- Sirdalud
- Ternelin
- Tizanidinum
- Sirdalud (TN)
- Tizanidina [INN-Spanish]
- Tizanidine (INN)
- Tizanidine [INN:BAN]
- Tizanidinum [INN-Latin]
- Zanaflex (TN)
- 5-Chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole
- 5-chloro-4-(2-imidazolin-2-yl-amino)-2,1,3-benzothiadiazole
- 5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-2,1,3-benzothiadiazol-4-amine
- 6AI06C00GW
- DTXCID203679
- CHEBI:63629
- RefChem:58565
- M03BX02
- Zanaflex
- MFCD00865192
- NCGC00160529-01
- 2,1,3-Benzothiadiazole, 5-chloro-4-(2-imidazolin-2-ylamino)-
- TIZANIDINE [INN]
- CAS-51322-75-9
- BRN 0618691
- UNII-6AI06C00GW
- Tizanidine?
- SR-01000765392
- Tizanidine (Standard)
- TIZANIDINE [MI]
- TIZANIDINE [VANDF]
- TIZANIDINE [WHO-DD]
- SCHEMBL60334
Reported adverse events
- Constipation
- Vomiting
- Dizziness
- Bradycardia
- Amblyopia
- Asthenia
- Dyskinesia
- Infection
- Nervousness
- Pharyngitis
- Rhinitis
- Somnolence
Look up TIZANIDINE in the interactive SynDRA portal →